miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer
Figure 2
Kaplan-Meier survival curves of GC patients. The overall survival rate in patients with high miR-21 expression was significantly lower than that in those with low miR-21 expression ().